FDA Approves EC-18 for Phase 2 Clinical Trials Targeting ARDS in COVID-19 Patients: Led by Duke Infectious Disease Expert Dr. Cameron Robert Wolfe

South Korean-based Enzychem Lifesciences (KOSDAQ: 183490) just announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to evaluate its lead therapeutic candidate EC-18, in a Phase 2 clinical trial in...

Chung-Ang University Research Team Study Makes Connection between ADHD & Internet Gaming Disorder

Korea’s Chung-Ang University Hospital investigators from its Online Game Clinic and Research Center conducted a study to conclude that attention deficit hyperactivity disorder (ADHD) is a common comorbidity with Internet Gaming Disorder (IDG), an apparent condition...

Pin It on Pinterest